Major depressive disorder is a devastating mental illness leading to a lifetime prevalence of
higher than 16% on individuals. The treatment delay and inevitable adverse effects are …

Objectives Depression is a widespread mental disorder in which nearly half of the affected
people have recurrent symptoms. Drug combinations may produce cumulative adverse …

Curcumin, an active ingredient of Curcuma longa Linn (Zingiberaceae), has shown potential
antidepressant‐like activity in animal studies. The objectives of this trial were to compare the …

Background Curcumin, the principal curcuminoid derived from the spice turmeric, influences
several biological mechanisms associated with major depression, namely those associated …

Major depression is a common, recurrent, and chronic disease that negatively affects the
quality of life and increases the risk of mortality. Several studies have demonstrated that …

Introduction There is growing interest in the use of curcumin, a plant polyphenol with potent
anti-inflammatory, anti-oxidant, and neuroprotective properties, as a novel antidepressant …

Depression is one of the most common but serious psychiatric disorders affecting millions of
people globally, which has become increasingly prevalent during the past few decades. To …

Background: Depression is a severe, chronic, and recurring mental health disorder, which
prevalence and morbimortality have increased in recent years. Several theories are …

Major depressive disorder (MDD) is one of the most prevalent and debilitating disorders.
Current available treatments are somehow limited, so alternative therapeutic approaches …

Major depression, a debilitating psychiatric disorder, is predicted to be the second most
prevalent human illness by the year 2020. Various antidepressants, ranging from …